SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+10.43%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$260M
AUM Growth
+$260M
(+21%)
Cap. Flow
+$28.4M
Cap. Flow
% of AUM
10.91%
Top 10 Holdings %
Top 10 Hldgs %
28.77%
Holding
78
New
17
Increased
25
Reduced
14
Closed
14
Top Buys
| 1 |
Eli Lilly
LLY
|
$6.83M |
| 2 |
Merck
MRK
|
$6.45M |
| 3 |
AstraZeneca
AZN
|
$5.27M |
| 4 |
Cencora
COR
|
$4.9M |
| 5 |
Cigna
CI
|
$4.25M |
Top Sells
| 1 |
AbbVie
ABBV
|
$7.1M |
| 2 |
Universal Health Services
UHS
|
$6.51M |
| 3 |
Cardinal Health
CAH
|
$5.01M |
| 4 |
Smith & Nephew
SNN
|
$3.82M |
| 5 |
UnitedHealth
UNH
|
$3.54M |
Sector Composition
| 1 | Healthcare | 93.84% |
| 2 | Energy | 1.15% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.4B
| $4.67M | 1.8% |
35,000
+17,813
| +104% | +$2.38M |
|
27
Zimmer Biomet
ZBH
$21B
| $4.46M | 1.71% |
40,000
+22,203
| +125% | +$2.47M |
|
28
Align Technology
ALGN
$10.3B
| $4.45M | 1.71% |
13,000
-5,000
| -28% | -$1.71M |
|
|
29
Cigna
CI
$80.3B
| $4.25M | 1.63% |
+25,000
| New | +$4.25M |
|
30
Illumina
ILMN
$15.8B
| $4.19M | 1.61% |
15,000
-5,000
| -25% | -$1.4M |
|
31
Qiagen
QGEN
$10.1B
| $4.16M | 1.6% |
115,000
+40,000
| +53% | +$1.45M |
|
32
Sarepta Therapeutics
SRPT
$1.78B
| $3.97M | 1.52% |
30,000
| – | – |
|
|
BLUE
33
DELISTED
bluebird bio
BLUE
| $3.92M | 1.51% |
25,000
+15,000
| +150% | +$2.35M |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $3.91M | 1.5% |
25,000
+10,000
| +67% | +$1.57M |
|
|
ESRX
35
DELISTED
Express Scripts Holding Company
ESRX
| $3.86M | 1.48% |
+50,000
| New | +$3.86M |
|
|
ALXN
36
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.73M | 1.43% |
30,000
| – | – |
|
37
Agilent Technologies
A
$35.7B
| $3.71M | 1.43% |
60,000
+20,000
| +50% | +$1.24M |
|
|
LOXO
38
DELISTED
Loxo Oncology, Inc
LOXO
| $3.47M | 1.33% |
20,000
+2,500
| +14% | +$434K |
|
39
Quest Diagnostics
DGX
$20.3B
| $3.3M | 1.27% |
+30,000
| New | +$3.3M |
|
40
Bausch Health
BHC
$2.74B
| $3.25M | 1.25% |
140,000
+10,000
| +8% | +$232K |
|
|
LHCG
41
DELISTED
LHC Group LLC
LHCG
| $3M | 1.15% |
35,000
| – | – |
|
42
Dr. Reddy's Laboratories
RDY
$11.8B
| $2.9M | 1.11% |
90,000
+34,287
| +62% | +$1.1M |
|
|
TSRO
43
DELISTED
TESARO, Inc.
TSRO
| $2.67M | 1.03% |
60,000
+31,729
| +112% | +$1.41M |
|
|
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.5M | 0.96% |
+55,000
| New | +$2.5M |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $2.38M | 0.92% |
+30,000
| New | +$2.38M |
|
46
Novo Nordisk
NVO
$251B
| $2.31M | 0.89% |
+50,000
| New | +$2.31M |
|
|
WMGI
47
DELISTED
Wright Medical Group Inc
WMGI
| $2.2M | 0.85% |
+84,900
| New | +$2.2M |
|
48
Agios Pharmaceuticals
AGIO
$2.19B
| $2.11M | 0.81% |
25,000
+4,981
| +25% | +$420K |
|
49
CRISPR Therapeutics
CRSP
$4.71B
| $2.06M | 0.79% |
+35,000
| New | +$2.06M |
|
|
EVHC
50
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $1.98M | 0.76% |
45,000
-60,000
| -57% | -$2.64M |
|